𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Stimulation of in vitro motility ofChlamydomonas axonemes by inhibition of cAMP-dependent phosphorylation

✍ Scribed by Hasegawa, Etsuko ;Hayashi, Hiroshi ;Asakura, Sho ;Kamiya, Ritsu


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
948 KB
Volume
8
Category
Article
ISSN
0886-1544

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Regulation of sperm flagellar motility b
✍ Charles J. Brokaw πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 709 KB

There is substantial evidence that CAMP-dependent phosphorylation is involved in the activation of motility of spermatozoa as they are released from storage in the male reproductive tract. This evidence includes observations that in vivo activation of motility can be inhibited by protein kinase inhi

Inhibition of forskolin-stimulated cAMP
✍ Kenneth Olivier Jr.; Jing Liu; Carey Pope πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 164 KB

## Abstract Parathion (PS) and chlorpyrifos (CPF) are organophosphorus insecticides, which elicit toxicity following biotransformation to the potent acetylcholinesterase inhibitors, paraoxon (PO) and chlorpyrifos oxon (CPO). Both oxons have also been shown to interact directly with muscarinic recep

Dose-dependent inhibition of phospholipa
✍ G. Petroianu; U. Helfrich; A. Schmitt; W. Bergler; R. RΓΌfer πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 1 views

To establish the dose dependency of phospholipase A 2 (PLA 2 ) inhibition by the organophosphorus compound (OPC) paraoxon (POX), human platelet membranes were incubated after Ca 2+ removal (to inactivate the PLA 2 ) with 0.3, 1 and 3 g ml ؊1 POX for 5, 30 and 60 min each. The PLA 2 activity (pmol mg

cAMP-dependent phosphorylation of CYP2B1
✍ Barbara Oesch-Bartlomowicz; Bernd Richter; Roger Becker; Stephan Vogel; Palghat πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 200 KB

An important feature of cytochrome P450 (CYP) 2B1 is its high ability to convert the prodrug cyclophosphamide (CPA) to therapeutically cytotoxic metabolites, resulting in interstrand DNA-cross-linking and cell death. We have examined whether and how the phosphorylation of CYP2B1 influences CPA metab